These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 7143358)

  • 21. Selectivity of F8-actinomycin D for RNA:DNA hybrids and its anti-leukemia activity.
    Takusagawa F; Takusagawa KT; Carlson RG; Weaver RF
    Bioorg Med Chem; 1997 Jun; 5(6):1197-207. PubMed ID: 9222513
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The interaction of 7-substituted actinomycin D analogs with DNA.
    Sengupta SK; Schaer D
    Biochim Biophys Acta; 1978 Nov; 521(1):89-100. PubMed ID: 568940
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In vitro and in vivo antitumor effects of novel actinomycin D analogs with amino acid substituted in the cyclic depsipeptides.
    Zhang BZ; Wang KR; Yan JX; Zhang W; Song JJ; Ni JM; Wang R
    Peptides; 2010 Apr; 31(4):568-73. PubMed ID: 20045716
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Synthesis and properties of some peptide analogues of actinomycin D.
    Mauger AB; Stuart OA; Katz E
    J Med Chem; 1991 Apr; 34(4):1297-301. PubMed ID: 1707976
    [TBL] [Abstract][Full Text] [Related]  

  • 25. New actinomycin D analogues as superior chemotherapeutic agents against primary and advanced colon tumors and colon xenografts in nude mice.
    Sengupta SK; Kogan Y; Kelly C; Szabo J
    J Med Chem; 1988 Apr; 31(4):768-74. PubMed ID: 3351854
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Synthesis of actinomycin analogues. IV. Synthesis of 2-amino-4, 6-dimethylphe-noxazone-(3)-1, 9-bis-peptides].
    Li SW; Zheng YP; Gao YS
    Yao Xue Xue Bao; 1982 May; 17(5):338-43. PubMed ID: 6184943
    [No Abstract]   [Full Text] [Related]  

  • 27. Biological, proton-magnetic-resonance- and ultraviolet-spectroscopic evidence for a molecular complex of actinomycin D and 10,11-dihydro-3H-naphth (1,2-g)indazol-7-ol.
    Chesnut RW; Durham NN; Mawdsley E; Thyvelikakath GX; Berlin KD; Fung BM
    Biochem J; 1974 Dec; 143(3):789-92. PubMed ID: 4218957
    [TBL] [Abstract][Full Text] [Related]  

  • 28. 7-Substituted actinomycin D (NSC-3053) analogs as fluorescent DNA-binding and experimental antitumor agents.
    Modest EJ; Sengupta SK
    Cancer Chemother Rep; 1974; 58(1):35-48. PubMed ID: 4812836
    [No Abstract]   [Full Text] [Related]  

  • 29. [Actinomycin D and its mechanisms of action].
    Koba M; Konopa J
    Postepy Hig Med Dosw (Online); 2005; 59():290-8. PubMed ID: 15995596
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Binding of actinomycin D to DNA: evidence for a nonclassical high-affinity binding mode that does not require GpC sites.
    Snyder JG; Hartman NG; D'Estantoit BL; Kennard O; Remeta DP; Breslauer KJ
    Proc Natl Acad Sci U S A; 1989 Jun; 86(11):3968-72. PubMed ID: 2726760
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Modifications of actinomycin D structure as example of actinomycins structure-activity relationship].
    Koba M
    Postepy Hig Med Dosw (Online); 2005; 59():276-82. PubMed ID: 15995594
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Binding of actinomycin D to the T(G)nT motif of double-stranded DNA: determination of the guanine requirement in nonclassical, non-GpC binding sites.
    Bailey SA; Graves DE; Rill R
    Biochemistry; 1994 Sep; 33(38):11493-500. PubMed ID: 7918362
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Actinomycin DO inhibition of RNA biosynthesis and its interaction with DNA preparations].
    Devan ML; Orlova TI; Silaev AB
    Antibiotiki; 1975 Mar; 20(3):243-8. PubMed ID: 806255
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Anti-leukemia selectivity in actinomycin analogues.
    Takusagawa F; Carlson RG; Weaver RF
    Bioorg Med Chem; 2001 Mar; 9(3):719-25. PubMed ID: 11310607
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparative antitumor activity of actinomycin analogs in mice bearing Ridgway osteogenic sarcoma or P388 leukemia.
    Rose WC; Trader MW; Laster WR; Schabel FM
    Cancer Treat Rep; 1978 May; 62(5):779-89. PubMed ID: 77730
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Interactinos of DNA with low molecular weight ligands of various structures. I. Complexes of DNA with actinomycin and its simple analogs].
    Krivtsova MA; Moroshkina EB; Khamman Kh; Glibin EN; Frisman EV
    Mol Biol (Mosk); 1981; 15(3):613-21. PubMed ID: 7254212
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Decreased retention of actinomycin D as the basis for cross-resistance in anthracycline-resistant sublines of P388 leukemia.
    Inaba M; Johnson RK
    Cancer Res; 1977 Dec; 37(12):4629-34. PubMed ID: 922743
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Actinomycin and antitumor antibiotics.
    Young CW
    Am J Clin Pathol; 1969 Aug; 52(2):130-7. PubMed ID: 5798361
    [No Abstract]   [Full Text] [Related]  

  • 39. Synthesis of actinomycin D lactam, [1',1'-bis(L-threo- , -diaminobutyric acid)]actinomycin D.
    Atherton E; Patel RP; Sano Y; Meienhofer J
    J Med Chem; 1973 Apr; 16(4):355-8. PubMed ID: 4197709
    [No Abstract]   [Full Text] [Related]  

  • 40. Antimutagenic activity of actinomycin D and basic fuchsine in Saccharomyces cerevisiae.
    Puglisi PP
    Mol Gen Genet; 1968; 103(3):248-52. PubMed ID: 5713664
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.